These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18767376)

  • 1. Reccurent erythema migrans as a persistent infection.
    Svecová D; Gavornik P
    Epidemiol Mikrobiol Imunol; 2008 Aug; 57(3):97-100. PubMed ID: 18767376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?
    Logar M; Lotric-Furlan S; Maraspin V; Cimperman J; Jurca T; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):945-50. PubMed ID: 10666806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multilocular erythema migrans in borreliosis].
    Krischer S; Ott H; Barker M; Frank J; Erdmann S
    Klin Padiatr; 2004; 216(4):236-7. PubMed ID: 15284948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance.
    Hunfeld KP; Ruzić-Sabljić E; Norris DE; Kraiczy P; Strle F
    Int J Med Microbiol; 2006 May; 296 Suppl 40():233-41. PubMed ID: 16530006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
    Fürst B; Glatz M; Kerl H; Müllegger RR
    Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythema migrans with multiple lesions].
    Constantin C; Peter O; Cerottini J; Derighetti M; Panizzon R; Guggisberg D
    Ann Dermatol Venereol; 2000 May; 127(5):513-6. PubMed ID: 10863185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Borrelial erythema of the face].
    de Heller-Milev M; Peter O; Panizzon RG; Laffitte E
    Ann Dermatol Venereol; 2008 Dec; 135(12):852-4. PubMed ID: 19084697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lyme disease. Recognising and treating erythema migrans.
    Prescrire Int; 2015 Oct; 24(164):247-9. PubMed ID: 26594731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythema migrans.
    Nadelman RB
    Infect Dis Clin North Am; 2015 Jun; 29(2):211-39. PubMed ID: 25999220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reinfection in Lyme borreliosis].
    Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Swierzbińska R; Moniuszko A; Pawlak-Zalewska W
    Pol Merkur Lekarski; 2008 Sep; 25(147):257-9. PubMed ID: 19112844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
    Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM
    Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythema migrans in the immunocompromised host.
    Maraspin V; Lotric-Furlan S; Cimperman J; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):923-32. PubMed ID: 10666803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions.
    Wormser GP; Masters E; Nowakowski J; McKenna D; Holmgren D; Ma K; Ihde L; Cavaliere LF; Nadelman RB
    Clin Infect Dis; 2005 Oct; 41(7):958-65. PubMed ID: 16142659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Re-infection with Borrelia burgdorferi s.l in a patient with a history of neuroborreliosis--case report].
    Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Swierzbińska R; Moniuszko A; Pawlak-Zalewska W
    Pol Merkur Lekarski; 2008 Sep; 25(147):254-6. PubMed ID: 19112843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and epidemiological findings for patients with erythema migrans. Comparison of cohorts from the years 1993 and 2000.
    Strle F; Videcnik J; Zorman P; Cimperman J; Lotric-Furlan S; Maraspin V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):493-7. PubMed ID: 12422589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinfection and relapse in early Lyme disease.
    Krause PJ; Foley DT; Burke GS; Christianson D; Closter L; Spielman A;
    Am J Trop Med Hyg; 2006 Dec; 75(6):1090-4. PubMed ID: 17172372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary and multiple erythema migrans in children: comparison of demographic, clinical and laboratory findings.
    Arnez M; Pleterski-Rigler D; Luznik-Bufon T; Ruzic-Sabljić E; Strle F
    Infection; 2003 Dec; 31(6):404-9. PubMed ID: 14735383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoblot analysis of the seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans.
    Glatz M; Fingerle V; Wilske B; Ambros-Rudolph C; Kerl H; Müllegger RR
    Dermatology; 2008; 216(2):93-103. PubMed ID: 18216470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early diagnosis of Lyme borreliosis].
    Hofmann H
    MMW Fortschr Med; 2006 Jun; 148(25):32, 34, 36. PubMed ID: 16859158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.